Status:
COMPLETED
Peers LEAD Plus Healthy Living With Diabetes (HLWD)
Lead Sponsor:
University of Wisconsin, Madison
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
20-90 years
Phase:
NA
Brief Summary
The specific goal of this project is to decrease diabetes-related morbidity among African Americans (AAs) in Milwaukee through the integration of Peers LEAD, a culturally-appropriate program to increa...
Detailed Description
This project represents the next phase of prior work at the University of Wisconsin School of Pharmacy to create and implement community-based programs for AAs with diabetes that focus on improving me...
Eligibility Criteria
Inclusion
- Shared Inclusion Criteria for Ambassadors and Buddies:
- Self-identify as AA
- Can speak/read English
- Self-report being prescribed one oral or injectable diabetes medication
- Access to/can use a cellular phone, tablet or computer to join a web-based meeting by video camera during the study period
- Diagnosed with diabetes for ≥1 year (obtained by self-report or verified by electronic medical record)
- Will reside in the geographical area throughout the study period
- Inclusion Criteria Specific to Buddies:
- Self-reported nonadherence on the Adherence to Refills and Medications Scale for Diabetes (ARMS-D) scale
- Most recent A1c is ≥8% based on information collected at point of care A1c testing
- Inclusion Criteria Specific to Ambassadors:
- Self-reported adherence on the Adherence to Refills and Medications Scale for Diabetes (ARMS-D) scale
- Most recent A1c is \<8% based on point of care A1c test
- Willing to provide support to a Buddy and track phone conversations
- Willing to attend all training sessions and meetings related to being an Ambassador
- Shared Exclusion Criteria for Ambassadors and Buddies:
- Diagnosed psychiatric disorder
- Older than 65-years old with a history of severe hypoglycemia requiring medical assistance or glucagon administration
- Exclusion Criteria Specific to Buddies:
- Currently participating in another diabetes lifestyle self-management or medication adherence program
Exclusion
Key Trial Info
Start Date :
April 19 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 22 2021
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT04857411
Start Date
April 19 2021
End Date
November 22 2021
Last Update
February 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Community Locations
Milwaukee, Wisconsin, United States, 53202